HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
501	9074 Barbieri S, Hofele K, Wiederhold KH, Probst A, Mistl C, et al. Mouse models of alpha-synucleinopathy and Lewy pathology - alpha- synuclein expression in transgenic mice NEUROPATHOLOGY AND GENETICS OF DEMENTIA. 2001; 487: 147-167	5	6	54	110
502	10208 Ingelsson M, Hyman BT Disordered proteins in dementia ANNALS OF MEDICINE. 2002; 34 (4): 259-271	6	8	54	150
503	11080 Pastor P, Tolosa E Progressive supranuclear palsy: clinical and genetic aspects CURRENT OPINION IN NEUROLOGY. 2002 AUG; 15 (4): 429-437	6	9	54	78
504	11222 Zoghbi HY, Botas J Mouse and fly models of neurodegeneration TRENDS IN GENETICS. 2002 SEP; 18 (9): 463-471	23	67	54	82
505	11766 Giasson BI, Lee VMY, Trojanowski JQ Interactions of amyloidogenic proteins NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 49-58	26	26	54	88
506	11836 Ferrer I, Barrachina M, Tolnay M, Rey MJ, Vidal N, et al. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease BRAIN PATHOLOGY. 2003 JAN; 13 (1): 62-78	15	24	54	95
507	11924 da Costa CA Recent advances on alpha-synuclein cell biology: Functions and dysfunctions CURRENT MOLECULAR MEDICINE. 2003 FEB; 3 (1): 17-24	8	11	54	80
508	12655 Wersinger C, Prou D, Vernier P, Sidhu A Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress FASEB JOURNAL. 2003 SEP; 17 (12): 2151-+	46	68	54	72
509	12852 Michalik A, Van Broeckhoven C Pathogenesis of polyglutamine disorders: aggregation revisited HUMAN MOLECULAR GENETICS. 2003 OCT 15; 12: R173-R186	12	59	54	154
510	13193 Hashimoto M, Kawahara K, Bar-On P, Rockenstein E, Crews L, et al. The role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 24 (3): 343-352	7	10	54	82
#	Date / Author / Journal	LCS	GCS	LCR	CR
511	14679 de Vrij FMS, Fischer DF, van Leeuwen FW, Hol EM Protein quality control in Alzheimer's disease by the ubiquitin proteasome system PROGRESS IN NEUROBIOLOGY. 2004 DEC; 74 (5): 249-270	12	50	54	236
512	14783 Delacourte A Tauopathies: recent insights into old diseases FOLIA NEUROPATHOLOGICA. 2005; 43 (4): 244-257	12	20	54	122
513	15202 Greenbaum EA, Graves CL, Mishizen-Eberz AJ, Lupoli MA, Lynch DR, et al. The E46K mutation in alpha-synuclein increases amyloid fibril formation JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 MAR 4; 280 (9): 7800-7807	85	95	54	67
514	17801 Boillee S, Vande Velde C, Cleveland DW ALS: A disease of motor neurons and their nonneuronal neighbors NEURON. 2006 OCT 5; 52 (1): 39-59	91	320	54	262
515	19167 Sihag RK, Inagaki M, Yamaguchi T, Shea TB, Pant HC Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments EXPERIMENTAL CELL RESEARCH. 2007 JUN 10; 313 (10): 2098-2109	12	43	54	142
516	21153 Barten DM, Albright CF Therapeutic strategies for Alzheimer's disease MOLECULAR NEUROBIOLOGY. 2008 JUN; 37 (2-3): 171-186	7	39	54	209
517	21760 Krolak-Salmon P, Seguin J, Perret-Liaudet A, Desestret V, Vighetto A, et al. Near a biological diagnosis of Alzheimer's disease and related disorders REVUE DE MEDECINE INTERNE. 2008 OCT; 29 (10): 785-793	0	0	54	123
518	22920 Kragh CL, Lund LB, Febbraro F, Hansen HD, Gai WP, et al. alpha-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 APR 10; 284 (15): 10211-10222	9	11	54	77
519	23156 Choonara YE, Pillay V, du Toit LC, Modi G, Naidoo D, et al. Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 JUN; 10 (6): 2510-2557	2	3	54	277
520	23432 Gasser T Molecular pathogenesis of Parkinson disease: insights from genetic studies EXPERT REVIEWS IN MOLECULAR MEDICINE. 2009 JUL 27; 11: Art. No. e22	7	18	54	152
#	Date / Author / Journal	LCS	GCS	LCR	CR
521	23621 Korenova M, Stozicka Z Improved Behavioral Response as a Valid Biomarker for Drug Screening Program in Transgenic Rodent Models of Tauopathies CELLULAR AND MOLECULAR NEUROBIOLOGY. 2009 SEP; 29 (6-7): 937-944	0	0	54	83
522	25559 Leugers CJ, Lee G Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 JUN 18; 285 (25): 19125-19134	0	0	54	87
523	26004 Reilly J, Rodriguez AD, Lamy M, Neils-Strunjas J Cognition, language, and clinical pathological features of non- Alzheimer's dementias: An overview JOURNAL OF COMMUNICATION DISORDERS. 2010 SEP-OCT; 43 (5): 438-452	0	0	54	170
524	26073 Kadir A, Nordberg A Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia JOURNAL OF NUCLEAR MEDICINE. 2010 SEP 1; 51 (9): 1418-1430	0	0	54	165
525	26344 Xie WL, Wan OW, Chung KKK New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 NOV; 1802 (11): 935-941	0	0	54	93
526	26536 Kalia SK, Kalia LV, McLean PJ Molecular Chaperones as Rational Drug Targets for Parkinson's Disease Therapeutics CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 741-753	0	0	54	171
527	6979 Harrison PJ The neuropathology of schizophrenia - A critical review of the data and their interpretation BRAIN. 1999 APR; 122: 593-624	125	808	53	428
528	9117 Panegyres PK The functions of the amyloid precursor protein gene REVIEWS IN THE NEUROSCIENCES. 2001; 12 (1): 1-39	7	24	53	476
529	10487 Lovestone S, McLoughlin DM Protein aggregates and dementia: is there a common toxicity? JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2002 FEB; 72 (2): 152-161	19	36	53	125
530	11079 Rosso SM, van Swieten JC New developments in frontotemporal dementia and parkinsonism linked to chromosome 17 CURRENT OPINION IN NEUROLOGY. 2002 AUG; 15 (4): 423-428	22	23	53	62
#	Date / Author / Journal	LCS	GCS	LCR	CR
531	11329 Tolnay M, Probst A Frontotemporal lobar degeneration - tau as a pied piper? NEUROGENETICS. 2002 OCT; 4 (2): 63-75	20	24	53	124
532	12671 Wersinger C, Prou D, Vernier P, Niznik HB, Sidhu A Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity MOLECULAR AND CELLULAR NEUROSCIENCE. 2003 SEP; 24 (1): 91-105	22	27	53	64
533	12957 Tarlac V, Storey E Role of proteolysis in polyglutamine disorders JOURNAL OF NEUROSCIENCE RESEARCH. 2003 NOV 1; 74 (3): 406-416	12	43	53	132
534	14187 Olanow CW, Perl DP, DeMartino GN, McNaught KSP Lewy-body formation is an aggresome-related process: a hypothesis LANCET NEUROLOGY. 2004 AUG; 3 (8): 496-503	54	91	53	89
535	14589 Necula M, Kuret J Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 NOV 26; 279 (48): 49694-49703	28	37	53	76
536	14758 Upadhya SC, Hegde AN Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies CURRENT PHARMACEUTICAL DESIGN. 2005; 11 (29): 3807-3828	2	9	53	208
537	15662 Ksiezak-Reding H, Wall JS Characterization of paired helical filaments by scanning transmission electron microscopy MICROSCOPY RESEARCH AND TECHNIQUE. 2005 JUL; 67 (3-4): 126-140	10	16	53	92
538	16479 Mufson EJ, Counts SE, Che SL, Ginsberg SD Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 197-222	5	15	53	141
539	17863 Sultana R, Perluigi M, Butterfield DA Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: Insights into mechanism of neuro degeneration from redox proteomics ANTIOXIDANTS & REDOX SIGNALING. 2006 NOV-DEC; 8 (11-12): 2021-2037	15	64	53	233
540	17955 Wood-Kaczmar A, Gandhi S, Wood NW Understanding the molecular causes of Parkinson's disease TRENDS IN MOLECULAR MEDICINE. 2006 NOV; 12 (11): 521-528	19	67	53	90
#	Date / Author / Journal	LCS	GCS	LCR	CR
541	19206 Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VMY, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration ACTA NEUROPATHOLOGICA. 2007 JUL; 114 (1): 5-22	229	229	53	80
542	20047 De Vos KJ, Grierson AJ, Ackerley S, Miller CCJ Role of axonal transport in neurodegenerative diseases ANNUAL REVIEW OF NEUROSCIENCE. 2008; 31: 151-173	33	90	53	143
543	20872 Muntane G, Dalfo E, Martinez A, Ferrer I Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies NEUROSCIENCE. 2008 APR 9; 152 (4): 913-923	11	17	53	73
544	21325 Hara K, Yasuhara T, Maki M, Matsukawa N, Masuda T, et al. Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke PROGRESS IN NEUROBIOLOGY. 2008 JUL; 85 (3): 318-334	10	15	53	122
545	21977 Vossel KA, Miller BL New approaches to the treatment of frontotemporal lobar degeneration CURRENT OPINION IN NEUROLOGY. 2008 DEC; 21 (6): 708-716	12	13	53	99
546	23203 Yokota O Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis PSYCHOGERIATRICS. 2009 JUN; 9 (2): 91-102	0	0	53	91
547	23335 Song W, Patel A, Qureshi HY, Han D, Schipper HM, et al. The Parkinson disease-associated A30P mutation stabilizes alpha- synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells JOURNAL OF NEUROCHEMISTRY. 2009 JUL; 110 (2): 719-733	1	3	53	81
548	24455 Santner A, Uversky VN Metalloproteomics and metal toxicology of alpha-synuclein METALLOMICS. 2010; 2 (6): 378-392	1	2	53	117
549	24687 Strong MJ The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS) JOURNAL OF THE NEUROLOGICAL SCIENCES. 2010 JAN 15; 288 (1-2): 1-12	10	12	53	168
550	25282 Franssens V, Boelen E, Anandhakumar J, Vanhelmont T, Buttner S, et al. Yeast unfolds the road map toward alpha-synuclein-induced cell death CELL DEATH AND DIFFERENTIATION. 2010 MAY; 17 (5): 746-753	2	3	53	79
#	Date / Author / Journal	LCS	GCS	LCR	CR
551	25447 Pawlyk AC, Cassel JA, Reitz AB Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis CURRENT PHARMACEUTICAL DESIGN. 2010 JUN; 16 (18): 2053-2073	1	1	53	334
552	25609 Pasquali L, Ruffoli R, Fulceri F, Pietracupa S, Siciliano G, et al. The Role of Autophagy: What can be Learned from the Genetic Forms of Amyotrophic Lateral Sclerosis CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 268-278	0	0	53	141
553	26757 Mazzio EA, Close F, Soliman KFA The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson's Disease INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2011 JAN; 12 (1): 506-569	0	0	53	557
554	5924 Combs CK, Coleman PD, O'Banion MK Developmental regulation and PKC dependence of Alzheimer's-type tau phosphorylations in cultured fetal rat hippocampal neurons DEVELOPMENTAL BRAIN RESEARCH. 1998 APR 17; 107 (1): 143-158	2	2	52	120
555	6364 Goedert M, Spillantini MG, Davies SW Filamentous nerve cell inclusions in neurodegenerative diseases CURRENT OPINION IN NEUROBIOLOGY. 1998 OCT; 8 (5): 619-632	143	186	52	92
556	8350 Jellinger KA, Rosler N Neuropathology and biological markers of degenerative dementias INTERNIST. 2000 JUN; 41 (6): 524-537	1	4	52	139
557	9322 Grant P, Sharma P, Pant HC Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism EUROPEAN JOURNAL OF BIOCHEMISTRY. 2001 MAR; 268 (6): 1534-1546	12	72	52	145
558	10366 Stevanin G, Durr A, Brice A Spinocerebellar ataxias caused by polyglutamine expansions TRIPLE REPEAT DISEASES OF THE NERVOUS SYSTEMS. 2002; 516: 47-77	1	9	52	203
559	11007 Gwinn-Hardy K Genetics of parkinsonism MOVEMENT DISORDERS. 2002 JUL; 17 (4): 645-656	23	72	52	145
560	11959 Ferrer I, Pastor P, Rey MJ, Munoz E, Puig B, et al. Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2003 FEB; 29 (1): 23-34	13	20	52	63
#	Date / Author / Journal	LCS	GCS	LCR	CR
561	12458 Orth M, Tabrizi SJ Models of Parkinson's disease MOVEMENT DISORDERS. 2003 JUL; 18 (7): 729-737	17	39	52	87
562	12937 Hashimoto M, Masliah E Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies NEUROCHEMICAL RESEARCH. 2003 NOV; 28 (11): 1743-1756	13	34	52	156
563	13398 Camicioli R, Fisher N Parkinson's disease with dementia and dementia with Lewy bodies CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2004 FEB; 31 (1): 7-21	5	12	52	282
564	13980 Meredith GE, Halliday GM, Totterdell S A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation PARKINSONISM & RELATED DISORDERS. 2004 JUN; 10 (4): 191-202	15	24	52	86
565	14769 Buracchio T, Arvanitakis Z, Gorbien M Dementia with Lewy bodies: Current concepts DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2005; 20 (5): 306-320	0	3	52	157
566	14868 Lowe J, Hand N, Mayer RJ Application of ubiquitin immunohistochemistry to the diagnosis of disease UBIQUITIN AND PROTEIN DEGRADATION, PT B. 2005; 399: 86-+	2	5	52	157
567	15275 Sarkar C, Deb P, Sharma MC Recent advances in embryonal tumours of the central nervous system CHILDS NERVOUS SYSTEM. 2005 APR; 21 (4): 272-293	1	8	52	236
568	16438 Pallas M, Camins A Molecular and biochemical features in Alzheimer's disease CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4389-4408	3	27	52	252
569	16492 Dillen K, Annaert W A two decade contribution of molecular cell biology to the centennial of Alzheimer's disease: Are we progressing toward therapy? INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 254. 2006; 254: 215-300	3	11	52	534
570	16615 Verdier Y, Penke B Polypeptide and protein aggregates with neurotoxic properties in neurodegenerative disorders: Emphasis on beta-amyloid-induced dysfunction of receptor-mediated signal transduction pathways CURRENT SIGNAL TRANSDUCTION THERAPY. 2006 JAN; 1 (1): 97-112	0	6	52	193
#	Date / Author / Journal	LCS	GCS	LCR	CR
571	17146 Kraemer BC, Burgess JK, Chen JH, Thomas JH, Schellenberg GD Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans HUMAN MOLECULAR GENETICS. 2006 MAY 1; 15 (9): 1483-1496	22	28	52	94
572	17735 Dickey CA, Petrucelli L Current strategies for the treatment of Alzheimer's disease and other tauopathies EXPERT OPINION ON THERAPEUTIC TARGETS. 2006 OCT; 10 (5): 665-676	5	9	52	122
573	18155 Cai LS, Innis RB, Pike VW Radioligand development for PET imaging of beta-amyloid (AD)-current status CURRENT MEDICINAL CHEMISTRY. 2007; 14 (1): 19-52	12	38	52	179
574	19780 Tansey MG, Mccoy MK, Frank-Cannon TC Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention EXPERIMENTAL NEUROLOGY. 2007 NOV; 208 (1): 1-25	17	67	52	327
575	20220 Gitler AD Beer and bread to brains and beyond: Can yeast cells teach us about neurodegenerative disease? NEUROSIGNALS. 2008; 16 (1): 52-62	5	6	52	142
576	20620 Bogaerts V, Theuns J, van Broeckhoven C Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria? GENES BRAIN AND BEHAVIOR. 2008 MAR; 7 (2): 129-151	5	19	52	286
577	20746 Jellinger KA, Attems J Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease ACTA NEUROPATHOLOGICA. 2008 APR; 115 (4): 427-436	18	26	52	103
578	21171 van Tijn P, Hol EM, van Leeuwen FW, Fischer DF The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype PROGRESS IN NEUROBIOLOGY. 2008 JUN; 85 (2): 176-193	3	12	52	220
579	21263 Cook C, Zhang YJ, Xu YF, Dickson DW, Petrucelli L TDP-43 in neurodegenerative disorders EXPERT OPINION ON BIOLOGICAL THERAPY. 2008 JUL; 8 (7): 969-978	9	9	52	78
580	22319 Anisimov SV Cell-based Therapeutic Approaches for Parkinson's Disease: Progress and Perspectives REVIEWS IN THE NEUROSCIENCES. 2009; 20 (5-6): 347-381	0	0	52	320
#	Date / Author / Journal	LCS	GCS	LCR	CR
581	23109 Beach TG, Adler CH, Lue LF, Sue LI, Bachalakuri J, et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction ACTA NEUROPATHOLOGICA. 2009 JUN; 117 (6): 613-634	15	20	52	85
582	23430 Bodner CR, Dobson CM, Bax A Multiple Tight Phospholipid-Binding Modes of alpha-Synuclein Revealed by Solution NMR Spectroscopy JOURNAL OF MOLECULAR BIOLOGY. 2009 JUL 24; 390 (4): 775-790	14	20	52	90
583	24486 Possin KL Visual spatial cognition in neurodegenerative disease NEUROCASE. 2010; 16 (6): 466-487	0	0	52	230
584	25455 Brunden KR, Ballatore C, Crowe A, Smith AB, Lee VMY, et al. Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors EXPERIMENTAL NEUROLOGY. 2010 JUN; 223 (2): 304-310	4	4	52	74
585	26028 van Dijk KD, Teunissen CE, Drukarch B, Jimenez CR, Groenewegen HJ, et al. Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach NEUROBIOLOGY OF DISEASE. 2010 SEP; 39 (3): 229-241	0	1	52	190
586	26251 Stetler RA, Gan Y, Zhang WT, Liou AK, Gao YQ, et al. Heat shock proteins: Cellular and molecular mechanisms in the central nervous system PROGRESS IN NEUROBIOLOGY. 2010 OCT; 92 (2): 184-211	0	2	52	322
587	26373 McEvoy LK, Brewer JB Quantitative structural MRI for early detection of Alzheimer's disease EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 NOV; 10 (11): 1675-1688	0	0	52	137
588	5577 Smith MA Alzheimer disease INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 42. 1998; 42: 1-54	32	122	51	397
589	7687 Murrell JR, Spillantini MG, Zolo P, Guazzelli M, Smith MJ, et al. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1999 DEC; 58 (12): 1207-1226	118	124	51	77
590	9088 Holzer M, Rodel L, Seeger G, Gartner U, Narz F, et al. Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology NEUROSCIENCE. 2001; 105 (4): 1041-1054	4	20	51	80
#	Date / Author / Journal	LCS	GCS	LCR	CR
591	11688 Festoff BW, Suo ZM, Citron BA Prospects for the pharmacotherapy of amyotrophic lateral sclerosis - Old strategies and new paradigms for the third millennium CNS DRUGS. 2003; 17 (10): 699-717	1	11	51	205
592	12934 Klucken J, McLean PJ, Gomez-Tortosa E, Ingelsson M, Hyman BT Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies NEUROCHEMICAL RESEARCH. 2003 NOV; 28 (11): 1683-1691	7	9	51	121
593	13436 Trimmer PA, Borland MK, Keeney PM, Bennett JP, Parker WD Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies JOURNAL OF NEUROCHEMISTRY. 2004 FEB; 88 (4): 800-812	24	51	51	76
594	13876 Zhang B, Higuchi M, Yoshiyama Y, Ishihara T, Forman MS, et al. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy JOURNAL OF NEUROSCIENCE. 2004 MAY 12; 24 (19): 4657-4667	57	57	51	52
595	13985 Martin FL, Williamson SJM, Paleologou KE, Allsop D, El-Agnaf OMA alpha-synuclein and the pathogenesis of Parkinson's disease PROTEIN AND PEPTIDE LETTERS. 2004 JUN; 11 (3): 229-237	5	7	51	71
596	14742 Meredith SC Protein denaturation and aggregation - Cellular responses to denatured and aggregated proteins CELL INJURY: MECHANISMS, RESPONSES, AND REPAIR. 2005; 1066: 181-221	7	35	51	235
597	15037 Betarbet R, Sherer TB, Greenamyre JT Ubiquitin-proteasome system and Parkinson's diseases EXPERIMENTAL NEUROLOGY. 2005 FEB; 191: S17-S27	42	89	51	91
598	17911 Duka T, Rusnak M, Drolet RE, Duka V, Wersinger C, et al. Alpha-Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism FASEB JOURNAL. 2006 NOV; 20 (13): 2302-2312	17	18	51	61
599	20148 Zilka N, Kontsekova E, Novak M Chaperone-like Antibodies Targeting Misfolded Tau Protein: New Vistas in the Immunotherapy of Neurodegenerative Foldopathies JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (2): 169-179	6	7	51	100
600	20275 Rosner S, Giladi N, Orr-Urtreger A Advances in the genetics of Parkinson's disease ACTA PHARMACOLOGICA SINICA. 2008 JAN; 29 (1): 21-34	2	5	51	154

Date / Author / Journal

LCS

GCS

LCR

501

9074 Barbieri S, Hofele K, Wiederhold KH, Probst A, Mistl C, et al.

Mouse models of alpha-synucleinopathy and Lewy pathology - alpha- synuclein expression in transgenic mice

NEUROPATHOLOGY AND GENETICS OF DEMENTIA. 2001; 487: 147-167

110

502

10208 Ingelsson M, Hyman BT

Disordered proteins in dementia

ANNALS OF MEDICINE. 2002; 34 (4): 259-271

150

503

11080 Pastor P, Tolosa E

Progressive supranuclear palsy: clinical and genetic aspects

CURRENT OPINION IN NEUROLOGY. 2002 AUG; 15 (4): 429-437

504

11222 Zoghbi HY, Botas J

Mouse and fly models of neurodegeneration

TRENDS IN GENETICS. 2002 SEP; 18 (9): 463-471

505

11766 Giasson BI, Lee VMY, Trojanowski JQ

Interactions of amyloidogenic proteins

NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 49-58

506

11836 Ferrer I, Barrachina M, Tolnay M, Rey MJ, Vidal N, et al.

Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease

BRAIN PATHOLOGY. 2003 JAN; 13 (1): 62-78

507

11924 da Costa CA

Recent advances on alpha-synuclein cell biology: Functions and dysfunctions

CURRENT MOLECULAR MEDICINE. 2003 FEB; 3 (1): 17-24

508

12655 Wersinger C, Prou D, Vernier P, Sidhu A

Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress

FASEB JOURNAL. 2003 SEP; 17 (12): 2151-+

509

12852 Michalik A, Van Broeckhoven C

Pathogenesis of polyglutamine disorders: aggregation revisited

HUMAN MOLECULAR GENETICS. 2003 OCT 15; 12: R173-R186

154

510

13193 Hashimoto M, Kawahara K, Bar-On P, Rockenstein E, Crews L, et al.

The role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease

JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 24 (3): 343-352

Date / Author / Journal

LCS

GCS

LCR

511

14679 de Vrij FMS, Fischer DF, van Leeuwen FW, Hol EM

Protein quality control in Alzheimer's disease by the ubiquitin proteasome system

PROGRESS IN NEUROBIOLOGY. 2004 DEC; 74 (5): 249-270

236

512

14783 Delacourte A

Tauopathies: recent insights into old diseases

FOLIA NEUROPATHOLOGICA. 2005; 43 (4): 244-257

122

513

15202 Greenbaum EA, Graves CL, Mishizen-Eberz AJ, Lupoli MA, Lynch DR, et al.

The E46K mutation in alpha-synuclein increases amyloid fibril formation

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 MAR 4; 280 (9): 7800-7807

514

17801 Boillee S, Vande Velde C, Cleveland DW

ALS: A disease of motor neurons and their nonneuronal neighbors

NEURON. 2006 OCT 5; 52 (1): 39-59

320

262

515

19167 Sihag RK, Inagaki M, Yamaguchi T, Shea TB, Pant HC

Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments

EXPERIMENTAL CELL RESEARCH. 2007 JUN 10; 313 (10): 2098-2109

142

516

21153 Barten DM, Albright CF

Therapeutic strategies for Alzheimer's disease

MOLECULAR NEUROBIOLOGY. 2008 JUN; 37 (2-3): 171-186

209

517

21760 Krolak-Salmon P, Seguin J, Perret-Liaudet A, Desestret V, Vighetto A, et al.

Near a biological diagnosis of Alzheimer's disease and related disorders

REVUE DE MEDECINE INTERNE. 2008 OCT; 29 (10): 785-793

123

518

22920 Kragh CL, Lund LB, Febbraro F, Hansen HD, Gai WP, et al.

alpha-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 APR 10; 284 (15): 10211-10222

519

23156 Choonara YE, Pillay V, du Toit LC, Modi G, Naidoo D, et al.

Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 JUN; 10 (6): 2510-2557

277

520

23432 Gasser T

Molecular pathogenesis of Parkinson disease: insights from genetic studies

EXPERT REVIEWS IN MOLECULAR MEDICINE. 2009 JUL 27; 11: Art. No. e22

152

Date / Author / Journal

LCS

GCS

LCR

521

23621 Korenova M, Stozicka Z

Improved Behavioral Response as a Valid Biomarker for Drug Screening Program in Transgenic Rodent Models of Tauopathies

CELLULAR AND MOLECULAR NEUROBIOLOGY. 2009 SEP; 29 (6-7): 937-944

522

25559 Leugers CJ, Lee G

Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding

JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 JUN 18; 285 (25): 19125-19134

523

26004 Reilly J, Rodriguez AD, Lamy M, Neils-Strunjas J

Cognition, language, and clinical pathological features of non- Alzheimer's dementias: An overview

JOURNAL OF COMMUNICATION DISORDERS. 2010 SEP-OCT; 43 (5): 438-452

170

524

26073 Kadir A, Nordberg A

Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia

JOURNAL OF NUCLEAR MEDICINE. 2010 SEP 1; 51 (9): 1418-1430

165

525

26344 Xie WL, Wan OW, Chung KKK

New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 NOV; 1802 (11): 935-941

526

26536 Kalia SK, Kalia LV, McLean PJ

Molecular Chaperones as Rational Drug Targets for Parkinson's Disease Therapeutics

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 741-753

171

527

6979 Harrison PJ

The neuropathology of schizophrenia - A critical review of the data and their interpretation

BRAIN. 1999 APR; 122: 593-624

125

808

428

528

9117 Panegyres PK

The functions of the amyloid precursor protein gene

REVIEWS IN THE NEUROSCIENCES. 2001; 12 (1): 1-39

476

529

10487 Lovestone S, McLoughlin DM

Protein aggregates and dementia: is there a common toxicity?

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2002 FEB; 72 (2): 152-161

125

530

11079 Rosso SM, van Swieten JC

New developments in frontotemporal dementia and parkinsonism linked to chromosome 17

CURRENT OPINION IN NEUROLOGY. 2002 AUG; 15 (4): 423-428

Date / Author / Journal

LCS

GCS

LCR

531

11329 Tolnay M, Probst A

Frontotemporal lobar degeneration - tau as a pied piper?

NEUROGENETICS. 2002 OCT; 4 (2): 63-75

124

532

12671 Wersinger C, Prou D, Vernier P, Niznik HB, Sidhu A

Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity

MOLECULAR AND CELLULAR NEUROSCIENCE. 2003 SEP; 24 (1): 91-105

533

12957 Tarlac V, Storey E

Role of proteolysis in polyglutamine disorders

JOURNAL OF NEUROSCIENCE RESEARCH. 2003 NOV 1; 74 (3): 406-416

132

534

14187 Olanow CW, Perl DP, DeMartino GN, McNaught KSP

Lewy-body formation is an aggresome-related process: a hypothesis

LANCET NEUROLOGY. 2004 AUG; 3 (8): 496-503

535

14589 Necula M, Kuret J

Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 NOV 26; 279 (48): 49694-49703

536

14758 Upadhya SC, Hegde AN

Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies

CURRENT PHARMACEUTICAL DESIGN. 2005; 11 (29): 3807-3828

208

537

15662 Ksiezak-Reding H, Wall JS

Characterization of paired helical filaments by scanning transmission electron microscopy

MICROSCOPY RESEARCH AND TECHNIQUE. 2005 JUL; 67 (3-4): 126-140

538

16479 Mufson EJ, Counts SE, Che SL, Ginsberg SD

Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease

FUNCTIONAL GENOMICS AND PROTEOMICS IN THE CLINICAL NEUROSCIENCES. 2006; 158: 197-222

141

539

17863 Sultana R, Perluigi M, Butterfield DA

Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: Insights into mechanism of neuro degeneration from redox proteomics

ANTIOXIDANTS & REDOX SIGNALING. 2006 NOV-DEC; 8 (11-12): 2021-2037

233

540

17955 Wood-Kaczmar A, Gandhi S, Wood NW

Understanding the molecular causes of Parkinson's disease

TRENDS IN MOLECULAR MEDICINE. 2006 NOV; 12 (11): 521-528

Date / Author / Journal

LCS

GCS

LCR

541

19206 Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VMY, et al.

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

ACTA NEUROPATHOLOGICA. 2007 JUL; 114 (1): 5-22

229

542

20047 De Vos KJ, Grierson AJ, Ackerley S, Miller CCJ

Role of axonal transport in neurodegenerative diseases

ANNUAL REVIEW OF NEUROSCIENCE. 2008; 31: 151-173

143

543

20872 Muntane G, Dalfo E, Martinez A, Ferrer I

Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies

NEUROSCIENCE. 2008 APR 9; 152 (4): 913-923

544

21325 Hara K, Yasuhara T, Maki M, Matsukawa N, Masuda T, et al.

Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke

PROGRESS IN NEUROBIOLOGY. 2008 JUL; 85 (3): 318-334

122

545

21977 Vossel KA, Miller BL

New approaches to the treatment of frontotemporal lobar degeneration

CURRENT OPINION IN NEUROLOGY. 2008 DEC; 21 (6): 708-716

546

23203 Yokota O

Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis

PSYCHOGERIATRICS. 2009 JUN; 9 (2): 91-102

547

23335 Song W, Patel A, Qureshi HY, Han D, Schipper HM, et al.

The Parkinson disease-associated A30P mutation stabilizes alpha- synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells

JOURNAL OF NEUROCHEMISTRY. 2009 JUL; 110 (2): 719-733

548

24455 Santner A, Uversky VN

Metalloproteomics and metal toxicology of alpha-synuclein

METALLOMICS. 2010; 2 (6): 378-392

117

549

24687 Strong MJ

The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)

JOURNAL OF THE NEUROLOGICAL SCIENCES. 2010 JAN 15; 288 (1-2): 1-12

168

550

25282 Franssens V, Boelen E, Anandhakumar J, Vanhelmont T, Buttner S, et al.

Yeast unfolds the road map toward alpha-synuclein-induced cell death

CELL DEATH AND DIFFERENTIATION. 2010 MAY; 17 (5): 746-753

Date / Author / Journal

LCS

GCS

LCR

551

25447 Pawlyk AC, Cassel JA, Reitz AB

Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis

CURRENT PHARMACEUTICAL DESIGN. 2010 JUN; 16 (18): 2053-2073

334

552

25609 Pasquali L, Ruffoli R, Fulceri F, Pietracupa S, Siciliano G, et al.

The Role of Autophagy: What can be Learned from the Genetic Forms of Amyotrophic Lateral Sclerosis

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 268-278

141

553

26757 Mazzio EA, Close F, Soliman KFA

The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson's Disease

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2011 JAN; 12 (1): 506-569

557

554

5924 Combs CK, Coleman PD, O'Banion MK

Developmental regulation and PKC dependence of Alzheimer's-type tau phosphorylations in cultured fetal rat hippocampal neurons

DEVELOPMENTAL BRAIN RESEARCH. 1998 APR 17; 107 (1): 143-158

120

555

6364 Goedert M, Spillantini MG, Davies SW

Filamentous nerve cell inclusions in neurodegenerative diseases

CURRENT OPINION IN NEUROBIOLOGY. 1998 OCT; 8 (5): 619-632

143

186

556

8350 Jellinger KA, Rosler N

Neuropathology and biological markers of degenerative dementias

INTERNIST. 2000 JUN; 41 (6): 524-537

139

557

9322 Grant P, Sharma P, Pant HC

Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism

EUROPEAN JOURNAL OF BIOCHEMISTRY. 2001 MAR; 268 (6): 1534-1546

145

558

10366 Stevanin G, Durr A, Brice A

Spinocerebellar ataxias caused by polyglutamine expansions

TRIPLE REPEAT DISEASES OF THE NERVOUS SYSTEMS. 2002; 516: 47-77

203

559

11007 Gwinn-Hardy K

Genetics of parkinsonism

MOVEMENT DISORDERS. 2002 JUL; 17 (4): 645-656

145

560

11959 Ferrer I, Pastor P, Rey MJ, Munoz E, Puig B, et al.

Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2003 FEB; 29 (1): 23-34

Date / Author / Journal

LCS

GCS

LCR

561

12458 Orth M, Tabrizi SJ

Models of Parkinson's disease

MOVEMENT DISORDERS. 2003 JUL; 18 (7): 729-737

562

12937 Hashimoto M, Masliah E

Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies

NEUROCHEMICAL RESEARCH. 2003 NOV; 28 (11): 1743-1756

156

563

13398 Camicioli R, Fisher N

Parkinson's disease with dementia and dementia with Lewy bodies

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES. 2004 FEB; 31 (1): 7-21

282

564

13980 Meredith GE, Halliday GM, Totterdell S

A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation

PARKINSONISM & RELATED DISORDERS. 2004 JUN; 10 (4): 191-202

565

14769 Buracchio T, Arvanitakis Z, Gorbien M

Dementia with Lewy bodies: Current concepts

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2005; 20 (5): 306-320

157

566

14868 Lowe J, Hand N, Mayer RJ

Application of ubiquitin immunohistochemistry to the diagnosis of disease

UBIQUITIN AND PROTEIN DEGRADATION, PT B. 2005; 399: 86-+

157

567

15275 Sarkar C, Deb P, Sharma MC

Recent advances in embryonal tumours of the central nervous system

CHILDS NERVOUS SYSTEM. 2005 APR; 21 (4): 272-293

236

568

16438 Pallas M, Camins A

Molecular and biochemical features in Alzheimer's disease

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4389-4408

252

569

16492 Dillen K, Annaert W

A two decade contribution of molecular cell biology to the centennial of Alzheimer's disease: Are we progressing toward therapy?

INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 254. 2006; 254: 215-300

534

570

16615 Verdier Y, Penke B

Polypeptide and protein aggregates with neurotoxic properties in neurodegenerative disorders: Emphasis on beta-amyloid-induced dysfunction of receptor-mediated signal transduction pathways

CURRENT SIGNAL TRANSDUCTION THERAPY. 2006 JAN; 1 (1): 97-112

193

Date / Author / Journal

LCS

GCS

LCR

571

17146 Kraemer BC, Burgess JK, Chen JH, Thomas JH, Schellenberg GD

Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans

HUMAN MOLECULAR GENETICS. 2006 MAY 1; 15 (9): 1483-1496

572

17735 Dickey CA, Petrucelli L

Current strategies for the treatment of Alzheimer's disease and other tauopathies

EXPERT OPINION ON THERAPEUTIC TARGETS. 2006 OCT; 10 (5): 665-676

122

573

18155 Cai LS, Innis RB, Pike VW

Radioligand development for PET imaging of beta-amyloid (AD)-current status

CURRENT MEDICINAL CHEMISTRY. 2007; 14 (1): 19-52

179

574

19780 Tansey MG, Mccoy MK, Frank-Cannon TC

Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention

EXPERIMENTAL NEUROLOGY. 2007 NOV; 208 (1): 1-25

327

575

20220 Gitler AD

Beer and bread to brains and beyond: Can yeast cells teach us about neurodegenerative disease?

NEUROSIGNALS. 2008; 16 (1): 52-62

142

576

20620 Bogaerts V, Theuns J, van Broeckhoven C

Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?

GENES BRAIN AND BEHAVIOR. 2008 MAR; 7 (2): 129-151

286

577

20746 Jellinger KA, Attems J

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease

ACTA NEUROPATHOLOGICA. 2008 APR; 115 (4): 427-436

103

578

21171 van Tijn P, Hol EM, van Leeuwen FW, Fischer DF

The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype

PROGRESS IN NEUROBIOLOGY. 2008 JUN; 85 (2): 176-193

220

579

21263 Cook C, Zhang YJ, Xu YF, Dickson DW, Petrucelli L

TDP-43 in neurodegenerative disorders

EXPERT OPINION ON BIOLOGICAL THERAPY. 2008 JUL; 8 (7): 969-978

580

22319 Anisimov SV

Cell-based Therapeutic Approaches for Parkinson's Disease: Progress and Perspectives

REVIEWS IN THE NEUROSCIENCES. 2009; 20 (5-6): 347-381

320

Date / Author / Journal

LCS

GCS

LCR

581

23109 Beach TG, Adler CH, Lue LF, Sue LI, Bachalakuri J, et al.

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

ACTA NEUROPATHOLOGICA. 2009 JUN; 117 (6): 613-634

582

23430 Bodner CR, Dobson CM, Bax A

Multiple Tight Phospholipid-Binding Modes of alpha-Synuclein Revealed by Solution NMR Spectroscopy

JOURNAL OF MOLECULAR BIOLOGY. 2009 JUL 24; 390 (4): 775-790

583

24486 Possin KL

Visual spatial cognition in neurodegenerative disease

NEUROCASE. 2010; 16 (6): 466-487

230

584

25455 Brunden KR, Ballatore C, Crowe A, Smith AB, Lee VMY, et al.

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors

EXPERIMENTAL NEUROLOGY. 2010 JUN; 223 (2): 304-310

585

26028 van Dijk KD, Teunissen CE, Drukarch B, Jimenez CR, Groenewegen HJ, et al.

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach

NEUROBIOLOGY OF DISEASE. 2010 SEP; 39 (3): 229-241

190

586

26251 Stetler RA, Gan Y, Zhang WT, Liou AK, Gao YQ, et al.

Heat shock proteins: Cellular and molecular mechanisms in the central nervous system

PROGRESS IN NEUROBIOLOGY. 2010 OCT; 92 (2): 184-211

322

587

26373 McEvoy LK, Brewer JB

Quantitative structural MRI for early detection of Alzheimer's disease

EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 NOV; 10 (11): 1675-1688

137

588

5577 Smith MA

Alzheimer disease

INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 42. 1998; 42: 1-54

122

397

589

7687 Murrell JR, Spillantini MG, Zolo P, Guazzelli M, Smith MJ, et al.

Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1999 DEC; 58 (12): 1207-1226

118

124

590

9088 Holzer M, Rodel L, Seeger G, Gartner U, Narz F, et al.

Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology

NEUROSCIENCE. 2001; 105 (4): 1041-1054

Date / Author / Journal

LCS

GCS

LCR

591

11688 Festoff BW, Suo ZM, Citron BA

Prospects for the pharmacotherapy of amyotrophic lateral sclerosis - Old strategies and new paradigms for the third millennium

CNS DRUGS. 2003; 17 (10): 699-717

205

592

12934 Klucken J, McLean PJ, Gomez-Tortosa E, Ingelsson M, Hyman BT

Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies

NEUROCHEMICAL RESEARCH. 2003 NOV; 28 (11): 1683-1691

121

593

13436 Trimmer PA, Borland MK, Keeney PM, Bennett JP, Parker WD

Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies

JOURNAL OF NEUROCHEMISTRY. 2004 FEB; 88 (4): 800-812

594

13876 Zhang B, Higuchi M, Yoshiyama Y, Ishihara T, Forman MS, et al.

Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy

JOURNAL OF NEUROSCIENCE. 2004 MAY 12; 24 (19): 4657-4667

595

13985 Martin FL, Williamson SJM, Paleologou KE, Allsop D, El-Agnaf OMA

alpha-synuclein and the pathogenesis of Parkinson's disease

PROTEIN AND PEPTIDE LETTERS. 2004 JUN; 11 (3): 229-237

596

14742 Meredith SC

Protein denaturation and aggregation - Cellular responses to denatured and aggregated proteins

CELL INJURY: MECHANISMS, RESPONSES, AND REPAIR. 2005; 1066: 181-221

235

597

15037 Betarbet R, Sherer TB, Greenamyre JT

Ubiquitin-proteasome system and Parkinson's diseases

EXPERIMENTAL NEUROLOGY. 2005 FEB; 191: S17-S27

598

17911 Duka T, Rusnak M, Drolet RE, Duka V, Wersinger C, et al.

Alpha-Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism

FASEB JOURNAL. 2006 NOV; 20 (13): 2302-2312

599

20148 Zilka N, Kontsekova E, Novak M

Chaperone-like Antibodies Targeting Misfolded Tau Protein: New Vistas in the Immunotherapy of Neurodegenerative Foldopathies

JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (2): 169-179

100

600

20275 Rosner S, Giladi N, Orr-Urtreger A

Advances in the genetics of Parkinson's disease

ACTA PHARMACOLOGICA SINICA. 2008 JAN; 29 (1): 21-34

154

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records